| Recruitment status | Preinitiation |
| Unique ID issued by UMIN | UMIN000038379 |
| Receipt No. | R000043723 |
| Scientific Title | Reserch of nail care during cancer chemotherapy |
| Date of disclosure of the study information | 2019/10/25 |
| Last modified on | 2019/11/08 (Ver. 2) |
| Basic information | ||
| Public title | Reserch of nail care during cancer chemotherapy | |
| Acronym | Reserch of nail care during cancer chemotherapy | |
| Scientific Title | Reserch of nail care during cancer chemotherapy | |
| Scientific Title:Acronym | Reserch of nail care during cancer chemotherapy | |
| Region |
|
|
| Condition | |||
| Condition | Breast Cancer | ||
| Classification by specialty |
|
||
| Classification by malignancy | Malignancy | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To explore the effects of gel-nails and nail polish on finger nails on the quality of life (QOL) of breast cancer patients during chemotherapy. |
| Basic objectives2 | Others |
| Basic objectives -Others | Efficacy |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | FACT-B,FACT-Tax(before gel-nails and nail polish,3 times in chemtherapy,3 weeks after chemotherapy) |
| Key secondary outcomes | degrees of nail toxicity |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | No treatment |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 3 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | apply gel nails on finger nails every 3 weeks(four times) during adjuvant paclitaxel, then 3 week after the last dose of paclitaxel. | |
| Interventions/Control_2 | apply nail polish on finger nails every 3 weeks(four times) during adjuvant paclitaxel, then 3 week after the last dose of paclitaxel | |
| Interventions/Control_3 | None | |
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Female | |||
| Key inclusion criteria | 20 years old or older
Clinically diagnosed breast cancer Expected adjuvant paclitaxel after complete from of Anthracycline base adjuvant chemotherapy |
|||
| Key exclusion criteria | unable to obtain to informed consent
The physicians in charge judge it difficult for their patients to participate in the program. History of allergy by gel nail or nail polish. Severe nail disorder. |
|||
| Target sample size | 30 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | St. Luke's International Hospital | ||||||
| Division name | oncology center | ||||||
| Zip code | 104-8560 | ||||||
| Address | 9-1 Akashi-cho, Chuo-ku, Tokyo 104-8560, Japan | ||||||
| TEL | 03-3541-5151 | ||||||
| miohat@luke.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | St. Luke's International Hospital | ||||||
| Division name | oncology center | ||||||
| Zip code | 104-8560 | ||||||
| Address | 9-1 Akashi-cho, Chuo-ku, Tokyo 104-8560, Japan | ||||||
| TEL | 03-3541-5151 | ||||||
| Homepage URL | |||||||
| miohat@luke.ac.jp | |||||||
| Sponsor | |
| Institute | St. Luke's International Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | THE COSMETOLOGY RESEARCH FOUNDATION |
| Organization | |
| Division | |
| Category of Funding Organization | Non profit foundation |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | St. Luke's International University, Clinical Trial Office |
| Address | Akashi-cho, Chuo-ku, Tokyo 104-8560, Japan |
| Tel | 03-3541-5151 |
| kenkyukikaku@luke.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Preinitiation | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB | |||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000043723 |